Blaise Coleman, Endo International CEO
Endo adds to a pileup of bad news as lead drug flunks PhII study
Endo International is adding some clinical woes today on top of its toxic pileup of opioid litigations.
The Dublin-based pharma put out word Friday …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
